HIV/AIDS Treatment and Care : Clinical protocols for the European ...

HIV/AIDS TREATMENT AND CARE FOR INJECTING DRUG USERS
126. Carrieri MP et al. Impact of early versus late adherence to highly active antiretroviral therapy on immuno-virological
response: a 3-year follow-up study. Antiviral Therapy, 2003(a), 8:585–594.
127. Safren SA et al. Two strategies to increase adherence to HIV antiretroviral medication: life steps and
medication monitoring. Behaviour Research and Therapy, 2001, 39(10):1481–1496.
128. Simoni JM et al. Antiretroviral adherence interventions: a review of current literature and ongoing studies
Topics in HIV Medicine, 2003, 11(6):185–198.
129. Golin CE et al. Adherence counselling practices of generalist and specialist physicians caring for people
living with HIV in North Carolina. Journal of General Internal Medicine, 2004, 19(1):16–27.
130. Weber RL et al. Effect of individual cognitive behaviour intervention on adherence to antiretroviral
therapy: prospective randomized trial. Antiviral Therapy, 2004, 9(1):85–95.
131. Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction. Rockville, MD,
United States Department of Health and Human Services, Substance Abuse and Mental Health Services
Administration Center for Substance Abuse Treatment, 2004.
132. National clinical guidelines and procedures for the use of buprenorphine in the treatment of heroin
dependence; national drug strategy. Woden, ACT, Australia Department of Health and Ageing, 2001.
133. Alterman AI et al. EuropASI6. Philadelphia, University of Pennsylvania Treatment Research Institute.
134. ICD-10 symptom checklist for mental disorders: psychoactive substance use syndromes module. Geneva,
World Health Organization, 2004 (http://www.who.int/substance_abuse/research_tools/en/english_icd10.pdf,
accessed 11 July 2006).
135. Center for Substance Abuse Treatment, Clinical guidelines for the use of buprenorphine in the treatment
of opioid addiction. Rockville, MD, United States Department of Health and Human Services (DHHS)
Substance Abuse and Mental Health Services Administration (SMA), 2004 (Treatment Improvement
Protocol (TIP) Series 40, DHHS Publication No. (SMA) 04-3939).
136. Fry C, Rumbold G, Lintzeris N. The Blood Borne Virus Transmission Risk Assessment Questionnaire
(BBVTRAQ): administration and procedures manual. Melbourne, Turning Point Alcohol and Drug
Centre, 1998 (http://www.who.int/substance_abuse/research_tools/bloodbornevirusriskassessment, accessed
14 September 2006).
223